Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential.

Prediction: This High-Yield Dividend Stock Will Payout More in 2024

Enterprise Products Partners

Gaming and Leisure Properties

24/7 Wall St. Insights Traders are betting that the first federal funds rate cut will come as early as September.

3 High-Yield Dividend Stocks to Buy Before the Fed Slashes Interest Rates

My previous bullish thesis about Altria aged well as the stock substantially outperformed the broader market over the last several months. I think that the major strength of this stock is its 7.92% forward dividend yield, which I consider very safe based on the company's robust financial performance. The company is likely to sustain its strong financial performance for longer, despite the secular decline in traditional cigarettes, due to its rapid expansion into new, thriving niches.

Altria: A Massively Undervalued Dividend Champion

Archer-Daniels-Midland Company

Black Hills

California Water Service Group

Federal Realty Investment Trust

Fortis

Genuine Parts

Hormel Foods

Coca-Cola

Kenvue

Leggett & Platt

Middlesex Water

National Fuel Gas

Northwest Natural Gas

PPG Industries

SJW Group

Stanley Black & Decker

Sysco

Target

United Bankshares

Universal Corp

“What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.”—suredividend.com. The 53 Dividend Kings, screened as of August 6, represented 8 of 11 Morningstar Sectors. Broker-targeted top-ten net-gains ranged 9.36%-31.67% topped-by PPG, and Target. By yield, Altria tops-all. Top-ten August dogs: NFG, FRT, KVUE, FTS, UBSI, BKH, NWN, CDUAF, UVV, & MO averaged 4.92% in yield.

53 August Dividend Kings: Buy 7, Watch 9 More

Conagra Brands

Kraft Heinz

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields

Altria Group has outperformed the market with a 28.2% total return this year, despite missing the latest earnings estimates. While the firm's smokable segment has not performed too well, the growth in the oral tobacco category and the firm's new NJOY product category indicates meaningful growth potential. Using a dividend discount model, MO's fair value is estimated well-above the current share price, indicating significant upside potential for investors.

Altria: Our Best Bet In The Current Market

Altria's sales fell by 5% last quarter, and things may not get better soon. The stock's payout ratio looks safe, but the company's earnings got a boost from a one-time gain on a sale.

Is Altria's High-Yielding Dividend Still Safe?

Keurig Dr Pepper Inc

Kimberly-Clark

Let's break down some blue- chip stocks for stability when times get tough. This topic feels especially important now, with fears of recession rising.

3 Blue-Chip Stocks That Could Offer Stability in Uncertain Times

Altria Group has seen a strong year with shares up over 26% in 2024, breaking the $50 barrier after years below. Despite risks and negative stigma, MO's Q2 results show a profitable business with strong margins and growth potential in non-combustible products. MO's high dividend yield of 7.68% and commitment to annual dividend increases make it an attractive investment for income-producing portfolios.

Altria Group: After Climbing 26.60% YTD, Shares Can Head Higher, Yielding 7.68%

Altria's recent price divergence from the broader market is yet another demonstration of its hedging role. The role is very timely judging by the odds of a recession, its Q2 sales data, and the recent price elasticity data of its products. The combination of high yield and low P/E further enhances the potency of its hedging role.

Altria Q2, Cigarette Price Elasticity, And Market Panic

Ladder Capital

High-yield investor focusing on dividend quality. Two favorite high-yield stocks: Ladder Capital and Altria Group. Ladder is a commercial mortgage REIT that yields 7.9%.

The High Yield Club: 2 Of My Favorites

Altria missed expectations in Q2 amid continual revenue challenges in the combustible segment. NJOY momentum, however, remained favorable again. I expect MO to raise its dividend by 4.0% in the third quarter, which would give shares a forward dividend yield of 8%. I am now neutral on valuation, and downgrade shares to hold, given that they have reached my fair value target price of $49 per share.

Altria: 7.7% Yield, But Limited Upside (Rating Downgrade)

Altria has delivered relatively strong financial results in Q2, 2024, confirming the notion of a gradually growing business. Yet, considering these data points and the fact that the stock has delivered almost 30% in total returns since the issuance of my initial investment case, I have become less bullish. In this article, I explain the reasons why I have decided to keep my capital in MO, but stopped reinvesting the dividends or increasing the stake here.

Altria: Why I Have Stopped Reinvesting In This Dividend King (Rating Downgrade)

Altria (NYSE: MO), the big tobacco company, has a stock that has risen 10% in the last month, while Nasdaq's stock has dropped 3%.

America's Best Dividend Stock Thrives In Market Downturn

24/7 Insights Altria is a member of the Dividend Kings.

Want $500 in Passive Income: Invest This Much in Altria Stock

Consumers are smoking fewer and fewer cigarettes. Altria is fighting this headwind well enough with alternative products and stock buybacks.

Is It Too Late to Buy Altria Stock?

Altria Group, Inc.'s shares have surged by 15.3% since April, outperforming the S&P 500. Second-quarter financial results showed a decline in revenue and adjusted earnings, with market share erosion continuing. Bright spots included growth in NJOY vaping technology and on! nicotine pouches, but overall weakness persists.

The Market Is Undeterred By Altria Group's Slow Motion Train Wreck

Bristol-Myers

Johnson & Johnson

McDonald's

NextEra Energy

NEXTracker Inc

Pfizer

The market consistently offers opportunities in value stocks for bargain hunters willing to do the work and take risks. Most of the work is done here for you as I have identified value stocks that are cheaply priced.

Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore

Altria Group NYSE: MO is one of the world's “Big Three” tobacco companies and is in the consumer staples sector. Let's examine the firm's business segments and the state of the cigarette market.

Tobacco Giant's Shares Fall on EPS Miss, Lackluster Pouch Gains

British American Tobacco

Blackstone Secured Lending Fund

Tesla

Alphabet and Tesla had negative reactions to Q2 earnings reports. Economic data showed PCE increased 0.1% MoM, while consumer confidence declined for the 4th consecutive month. The Dividend Harvesting Portfolio had another positive week, reaching new highs in dividend income.

Dividend Harvesting Portfolio Week 178: $17,800 Allocated, $1,612.87 In Projected Dividends

The Altria Group stock price decreased by ~3% after the Q2 2024 earnings release. MO continues to struggle within its smokeable product portfolio and cannot offset negative volume effects with positive price/mix effects. Smoke-free products hold significant potential. However, much work remains before this potential can be properly realized.

Altria Group Is Falling Behind Its Peers, But I'm Holding

Altria's Q2 sales and earnings fell short of Wall Street's targets. The tobacco company also narrowed its full-year earnings guidance.

Why Altria Stock Is Falling Today

Altria Group, Inc. (NYSE:MO ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Mac Livingston - Vice President of Investor Relations Billy Gifford - Chief Executive Officer Sal Mancuso - Executive Vice President & Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Matt Smith - Stifel Callum Elliott - Bernstein Faham Baig - UBS Gaurav Jain - Barclays Owen Bennett - Jefferies Operator Good day everyone and welcome to the Altria Group 2024 Second Quarter and First Half Earnings Conference Call. Today's call is scheduled to last about one hour, including remarks by Altria's management and a question-and-answer session representative of the investment community and media on the call will be able to ask questions following the conclusion of the prepared remarks.

Altria Group, Inc. (MO) Q2 2024 Earnings Call Transcript

Altria's (MO) second-quarter 2024 results reflect strong pricing, while cigarette shipment volumes remain soft. Management narrows the adjusted EPS view for 2024.

Altria's (MO) Q2 Earnings Lag Estimates, Cigarette Volumes Drop

Marlboro maker Altria said on Wednesday it had sent data to the U.S. Food and Drug Administration on growth in illegal nicotine pouches, saying it echoed the early stages of a now massive black market for vapes in the country.

News for Altria Stock (MO)